Načítá se...
DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells
BACKGROUND: 5-fluorouracil (5-FU)-based chemotherapy is the standard treatment for advanced stage colorectal cancer (CRC) patients. Several groups including ours have reported that stage II-III colorectal cancer patients whose tumors retain DNA Mismatch repair (MMR) function derive a benefit from 5-...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Landes Bioscience
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3367669/ https://ncbi.nlm.nih.gov/pubmed/21814034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.12.8.17169 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|